News
Neuromodulation Professionals Join Pain Physicians at AAPM Annual Meeting
The 36th annual American Academy of Pain Medicine convened in National Harbor, MD in late February. The event is a culmination of the multiple disciplines in clinical practice, the latest research in a patient-centered approach, and emerging methods to treat people living with chronic pain. The overwhelming sentiment at the meeting was that treatments are not singular in nature but complementary an…
Neuromodulation Professionals Join Pain Physicians at AAPM Annual Meeting
The 36th annual American Academy of Pain Medicine convened in National Harbor, MD in late February. The event is a culmination of the multiple disciplines in clinical practice, the latest research in a patient-centered approach, and emerging methods to treat people living with chronic pain. The overwhelming sentiment at the meeting was that treatments are not singular in nature but complementary an…
Emerging Firms to Present at Bioelectronic Medicine Forum in NYC
Executives of several emerging bioelectronic medicine firms will present at the Third Annual Bioelectronic Medicine Forum, to take place on April 7, 2020 in New York City. The conference, produced , will also feature sessions related to investment, regulatory and reimbursement, and translational issues. Among the promising entrepreneurs tentatively scheduled to present are Ash Attia, CEO of Bionic…
Who Was First?
As is the case with most areas of science and engineering, the field of neurotechnology has moved forward as the result of pioneering discoveries that have led to new products, new therapeutic approaches, and new branches of investigation. As is also often the case, there can be disagreement among researchers as to who was the first to make that important discovery. Such was the case in the field of optics regarding who invented the laser.
Glial Cell Findings May Alter SCS Market Landscape
New findings on the role of glial cells in modulating pain may have a fundamental impact on the market for spinal cord stimulation systems. The topic was one of the major themes at the recent NANS conference in Las Vegas and at least one vendor has invested heavily in the new approach. In a keynote address at the meeting, Linda Watkins from the University of Colorado described the role that non-neuronal cells such as glia play in the pain pathway.
Neuromodulation Entrepreneurs Join Strategics at 23rd Annual NANS Meeting
The 23rd Annual meeting of the North American Neuromodulation Society took place in Las Vegas, NV, earlier this month—the last meeting at this venue before it moves to Orlando, FL next year. As one of the largest conferences on the topic of neuromodulation, this event brings together discoveries in basic and clinical neuroscience with innovations in neural engineering. This year the program featured a half-day session called Emerging Technology Forum.
Investors Join Entrepreneurs and Strategics at Bioelectronic Medicine Forum in NYC
About 85 executives and entrepreneurs took part in the second annual Bioelectronic Medicine Forum held in New York City earlier this month. The agenda featured four discussion panels covering topics like investments, digital health, regulatory and reimbursement, and future technology. More than a dozen entrepreneurs presented their ventures and technology innovations at the event and NBR editor Jam…
Neurotech Industry Veterans and Newcomers Attend 19th Leaders Forum in SF
About 120 neurotechnology professionals from industry, research, investment, and clinical fields gathered for the 19th annual Neurotech Leaders Forum in San Francisco earlier this month. Discussions ensued from current trends, recent opportunities, and on-going challenges. One of the highlights of this event is the exchange of new ideas and the dialogue with neurotech entrepreneurs. The keynote speakers this year each spoke of finding clues in the human nervous system—but from different perspectives.
The Two-Way Street
As it has in the past, the recent meeting of the North American Neuromodulation Society offered a host of scientific and clinical presentations that meshed nicely with commercial product offerings on the exhibit floor [see conference report, p7]. As we report in our article on page 1 of this issue, one such area of scientific advance that will likely have a tremendous impact on commercial product development is the role that glial cells play in the pain pathway.
New Sensing and Stim Devices Expand Epilepsy Market
The market for treating epilepsy and related seizure disorders stands to expand considerably in coming years. Several recent developments highlight progress in both commercial product development and clinical research. Technological advances in this field include both enhanced neurosensing systems as well as neuromodulation systems. At the American Epilepsy Society meeting earlier this month, Neuro…
